Similarly, in Fas/CD95-mediated glioblastoma cells, a CD95L-independent CD95 signaling pathway has been identified, which contributes to the maintenance of malignant characteristics in glioma-initiating cells [32]. The gene discussed is FAS; the disease is glioblastoma.